Literature Collection

Magnifying Glass
Collection Insights

11K+

References

9K+

Articles

1500+

Grey Literature

4600+

Opioids & SU

The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Enter Search Term(s)
Year
Sort by
Order
Show
12257 Results
8442
Prenatal and Pediatric Primary Care-Based Child Obesity Prevention: Effects of Adverse Social Determinants of Health on Intervention Attendance and Impact
Type: Journal Article
Authors: C. Duh-Leong, M. J. Messito, M. W. Katzow, C. N. Kim, A. L. Mendelsohn, M. A. Scott, R. S. Gross
Year: 2024
Abstract:

Background: Adverse social determinants of health (SDoHs), specifically psychosocial stressors and material hardships, are associated with early childhood obesity. Less is known about whether adverse SDoHs modify the efficacy of early childhood obesity prevention programs. Methods: We conducted a secondary analysis of publicly insured birthing parent-child dyads with Latino backgrounds participating in a randomized controlled trial of the Starting Early Program (StEP), a child obesity prevention program beginning in pregnancy. We measured baseline adverse SDoHs categorized as psychosocial stressors (low social support, single marital status, and maternal depressive symptoms) and material hardships (food insecurity, housing disrepair, and financial difficulties) individually and cumulatively in the third trimester. Logistic regression models tested effects of adverse SDoHs on StEP attendance. We then tested whether adverse SDoHs moderated intervention impacts on weight at age 2 years. Results: We observed heterogeneous effects of adverse SDoHs on outcomes in 358 parent-child dyads. While housing disrepair decreased odds of higher attendance [adjusted odds ratio (aOR) 0.52, 95% confidence interval (CI): 0.29-0.94], high levels of psychosocial stressors doubled odds of higher attendance (aOR 2.36, 95% CI: 1.04-5.34). Similarly, while certain adverse SDoHs diminished StEP impact on weight (e.g., housing disrepair), others (e.g., high psychosocial stress) enhanced StEP impact on weight. Conclusions: Effects of adverse SDoHs on intervention outcomes depend on the specific adverse SDoH. Highest engagement and benefit occurred in those with high psychosocial stress at baseline, suggesting that StEP components may mitigate aspects of psychosocial stressors. Findings also support integration of adverse SDoH assessment into strategies to enhance obesity prevention impacts on families with material hardships. Trial Registration: This study is registered on clinicaltrials.gov: Starting Early Obesity Prevention Program (NCT01541761); https://clinicaltrials.gov/ct2/show/NCT01541761.

Topic(s):
Healthcare Disparities See topic collection
8443
Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes
Type: Journal Article
Authors: K. Kaltenbach, K. E. O'Grady, S. H. Heil, A. L. Salisbury, M. G. Coyle, G. Fischer, P. R. Martin, S. Stine, H. E. Jones
Year: 2018
Publication Place: Ireland
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
8444
Prenatal Opioid Exposure and Neurodevelopmental Outcomes
Type: Journal Article
Authors: J. J. Lee, N. Saraiya, M. W. Kuzniewicz
Year: 2023
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
8445
Prenatal opioid exposure and well-child care in the first 2 years of life: population-based cohort study
Type: Journal Article
Authors: A. Camden, T. To, T. Gomes, J. Ray, L. Bai, A. Guttmann
Year: 2023
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
8446
Prenatal substance use: Religious women report lower use rates, but do they use less?
Type: Journal Article
Authors: Andrea D. Clements, Natalie A. Cyphers
Year: 2020
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
8447
Prenatal Treatment and Outcomes of Women With Opioid Use Disorder
Type: Journal Article
Authors: S. B. Brogly, K. E. Saia, M. M. Werler, E. Regan, S. Hernandez-Diaz
Year: 2018
Abstract:

OBJECTIVE: To describe the characteristics, treatment, and outcomes of pregnant women with opioid use disorder. METHODS: Women attending an obstetric and addiction recovery clinic in Boston from 2015 to 2016 were enrolled in a prospective cohort study and followed through delivery (N=113). Buprenorphine or methadone was initiated clinically. The Addiction Severity Index was administered at enrollment. Prenatal and delivery data were systematically abstracted from medical charts. RESULTS: Most women in the cohort were non-Hispanic white (80.5%) with a mean age of 28 years. Few women were married (8.9%). More than half of the cohort had been incarcerated, 29.2% had current legal involvement, and 15.0% generally had unstable housing. A majority (70.8%) were infected with hepatitis C and histories of sexual (56.6%) and physical (65.5%) abuse were prevalent. Regular substance used included heroin (92.0%), injection heroin (83.2%), other opioids (69.0%), marijuana (73.5%), alcohol (56.6%), and cocaine (62.8%). Fifty-nine women (52.2%) were treated initially with prenatal buprenorphine and 54 (47.8%) with methadone; 49.6% also were taking concomitant psychotropic medications. Employment (0.766±0.289) and psychologic (0.375±0.187) Addiction Severity Index scores were the highest, indicating the most severe problems in these areas. Opioid use relapse did not differ by treatment (44.7% overall). Thirteen (22.5%) of 59 women treated with buprenorphine transitioned to methadone mainly because of positive opioid screens. Overall, 23.0% (n=26) of the cohort discontinued clinical care. The number of pregnancy losses was small (three therapeutic abortions, four miscarriages, one stillbirth), with an overall live birth rate of 90.8% (95% CI 82.7-95.9). CONCLUSION: These data on the social circumstances, substance use, treatment, and treatment outcomes of pregnant women with opioid use disorder may help clinicians to understand and treat this clinically complex population.

Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Measures See topic collection
,
Opioids & Substance Use See topic collection
8448
Prenatal treatment for opioid dependency: observations from a large inner-city clinic
Type: Journal Article
Authors: K. Saia, S. M. Bagley, E. M. Wachman, P. P. Patel, M. D. Nadas, S. B. Brogly
Year: 2017
Publication Place: England
Abstract: BACKGROUND: The objective of this study was to review changes in the prevalence of opioid use disorder in pregnancy, and to describe the prenatal care and neonatal outcomes following the implementation of buprenorphine treatment at a large US obstetrical clinic during the on-going opioid epidemic. METHODS: We conducted a retrospective cohort study of 310 women (332 pregnancies) with opioid use disorders and their neonates delivered between June 2006 and December 2010 at an obstetrical clinic in the US. Trends in patient volume, characteristics and outcomes by calendar year were assessed using the Cochran-Armitage test and linear regression. RESULTS: There was an almost two-fold increase in the volume of pregnant women treated annually from 2006 through 2010. Most women were treated with methadone (74%), with buprenorphine becoming more common over calendar time: 3.0% in 2006 to 41% in 2010. The mean dose of buprenorphine at delivery was: 11.4 mg in 2007, 14.1 mg in 2008, 14.1 mg in 2009, and 16.8 mg in 2010; an average increase of 2.1 mg year. There were no differences in mean methadone dose over time. From 2006 to 2010 there were increases in the prevalence of prescribed concomitant psychotropic medications and vaginal deliveries, and in the proportion of neonates treated pharmacologically for neonatal abstinence syndrome (NAS). NAS pharmacologic management also varied by calendar year with more use of neonatal morphine and clonidine in later years. CONCLUSIONS: The number of mother-infant pairs increased significantly from 2006 to 2010 and the clinical characteristics of these patients changed over time. Our experience reflects the rising increase in opioid use disorders in pregnancy and NAS, mandating the need for expansion of comprehensive prenatal care options for these women and their children.
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
8449
Prenatal treatment for opioid dependency: observations from a large inner-city clinic
Type: Journal Article
Authors: K. Saia, S. M. Bagley, E. M. Wachman, P. P. Patel, M. D. Nadas, S. B. Brogly
Year: 2017
Publication Place: England
Abstract: BACKGROUND: The objective of this study was to review changes in the prevalence of opioid use disorder in pregnancy, and to describe the prenatal care and neonatal outcomes following the implementation of buprenorphine treatment at a large US obstetrical clinic during the on-going opioid epidemic. METHODS: We conducted a retrospective cohort study of 310 women (332 pregnancies) with opioid use disorders and their neonates delivered between June 2006 and December 2010 at an obstetrical clinic in the US. Trends in patient volume, characteristics and outcomes by calendar year were assessed using the Cochran-Armitage test and linear regression. RESULTS: There was an almost two-fold increase in the volume of pregnant women treated annually from 2006 through 2010. Most women were treated with methadone (74%), with buprenorphine becoming more common over calendar time: 3.0% in 2006 to 41% in 2010. The mean dose of buprenorphine at delivery was: 11.4 mg in 2007, 14.1 mg in 2008, 14.1 mg in 2009, and 16.8 mg in 2010; an average increase of 2.1 mg year. There were no differences in mean methadone dose over time. From 2006 to 2010 there were increases in the prevalence of prescribed concomitant psychotropic medications and vaginal deliveries, and in the proportion of neonates treated pharmacologically for neonatal abstinence syndrome (NAS). NAS pharmacologic management also varied by calendar year with more use of neonatal morphine and clonidine in later years. CONCLUSIONS: The number of mother-infant pairs increased significantly from 2006 to 2010 and the clinical characteristics of these patients changed over time. Our experience reflects the rising increase in opioid use disorders in pregnancy and NAS, mandating the need for expansion of comprehensive prenatal care options for these women and their children.
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
8450
Prep uptake and methamphetamine use patterns in a 4-year u.S. National prospective cohort study of sexual and gender minority people, 2017–2022
Type: Journal Article
Authors: Yan Guo, Drew A. Westmoreland, Alexa B. D'Angelo, Chloe Mirzayi, Michelle Dearolf, Meredith Ray, Pedro B. Carneiro, David W. Pantalone, Adam W. Carrico, Viraj V. Patel, Sarit A. Golub, Sabina Hirshfield, Donald R. Hoover, Denis Nash, Christian Grov
Year: 2024
Topic(s):
Healthcare Disparities See topic collection
8451
Preparedness of Lithuanian general practitioners to provide mental healthcare services: A cross-sectional survey.
Type: Journal Article
Authors: Lina Jaruseviciene, Skirmante Sauliune, Gediminas Jarusevicius, Jeffrey Victor Lazarus
Year: 2014
Topic(s):
Education & Workforce See topic collection
8452
Preparing behavioral health clinicians for success and retention in rural safety net practices
Type: Journal Article
Authors: Donald E. Pathman, Lisa de Saxe Zerden, Mandi Gingras, Jessica Seel, Jackie Fannell, Brianna M. Lombardi
Year: 2024
Topic(s):
Healthcare Disparities See topic collection
,
Education & Workforce See topic collection
8453
Preparing for New Primary Care Models: The Role of Professional Case Management
Type: Journal Article
Authors: Hussein M. Tahan, Gerri Lamb, Ellen Fink-Samnick, Colleen Morley, Kathleen Moreo
Year: 2025
Topic(s):
Education & Workforce See topic collection
8454
Preparing placement supervisors for primary care: An interprofessional perspective from the UK
Type: Journal Article
Authors: Tony Emerson
Year: 2004
Publication Place: United Kingdom: Taylor & Francis
Topic(s):
Education & Workforce See topic collection
8455
Preparing Psychologists in Academic Health Centers for the Rapidly Changing Health Care Environment
Type: Journal Article
Authors: Justin M. Nash, Catherine Schuman
Year: 2012
Topic(s):
Education & Workforce See topic collection
8456
Preparing Social Work Students for Interprofessional Team Practice in Health-Care Settings
Type: Journal Article
Authors: Elena Delavega, Susan Neely-Barnes, Susan Elizabeth Elswick, Laura C. Taylor, Fawn Lindsey Pettet, Margaret A. Landry
Year: 2019
Publication Place: Thousand Oaks, California
Topic(s):
Education & Workforce See topic collection
8458
Prescribe To Prevent
Type: Web Resource
Year: 2015
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

8459
Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists
Type: Journal Article
Authors: J. K. Lim, J. P. Bratberg, C. S. Davis, T. C. Green, A . Y. Walley
Year: 2016
Abstract: In March of 2015, the United States Department of Health and Human Services identified 3 priority areas to reduce opioid use disorders and overdose, which are as follows: opioid-prescribing practices; expanded use and distribution of naloxone; and expansion of medication-assisted treatment. In this narrative review of overdose prevention and the role of prescribers and pharmacists in distributing naloxone, we address these priority areas and present a clinical scenario within the review involving a pharmacist, a patient with chronic pain and anxiety, and a primary care physician. We also discuss current laws related to naloxone prescribing and dispensing. This review was adapted from the Prescribe to Prevent online continuing medical education module created for prescribers and pharmacists (http://www.opioidprescribing.com/naloxone_module_1-landing).This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially. http://creativecommons.org/licenses/by-nc-nd/4.0.
Topic(s):
Opioids & Substance Use See topic collection
,
Education & Workforce See topic collection
8460
Prescribed and Penalized: The Detrimental Impact of Mandated Reporting for Prenatal Utilization of Medication for Opioid Use Disorder
Type: Journal Article
Authors: E. C. Work, S. Muftu, K. D. L. MacMillan, J. R. Gray, N. Bell, M. Terplan, H. E. Jones, J. Reddy, T. E. Wilens, S. F. Greenfield, J. Bernstein, D. M. Schiff
Year: 2023
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
,
Healthcare Policy See topic collection